{"id":378,"date":"2024-11-01T22:13:12","date_gmt":"2024-11-01T21:13:12","guid":{"rendered":"https:\/\/app.agence2d.be\/gbl\/?page_id=378"},"modified":"2024-11-04T21:36:06","modified_gmt":"2024-11-04T20:36:06","slug":"affidea-investment-case","status":"publish","type":"page","link":"https:\/\/app.agence2d.be\/gbl\/portfolio\/affidea-investment-case\/","title":{"rendered":"Affidea Investment case"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\tOverview<\/a>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\tInvestment case<\/a>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\tInfluence<\/a>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\tAffidea is benefiting from the sector\u2019s long-term structural tailwinds and its solid fundamentals and positioning:\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
  • Large and growing market (e.g., ageing population and increasing focus on preventive medicine)<\/li>
  • Resilience through economic cycles, given the critical nature of the services and market undersupply<\/li>
  • Barriers to entry from: (i) sticky long-term contracts, (ii) high capital requirements, (iii) complex regulations and license requirements and (iv) radiologist shortages<\/li><\/ul>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\tIn addition, the fragmented European market offers M&A opportunities, both in countries where Affidea is present and beyond.\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\tAffidea is well positioned to win:\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    • Diversification across geographies, payors (e.g., public and private), services and regulations<\/li>
    • Over-indexed to attractive complex modalities with higher growth<\/li>
    • Strong financial profile, with ongoing organic growth and solid M&A track record<\/li>
    • Margin improvement potential (e.g., best practice sharing, higher medical productivity by reducing doctors\u2019 administrative burden)<\/li>
    • Attractive additional opportunities from artificial intelligence and teleradiology<\/li><\/ul>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t

      The company\u2019s current focus lies on top-line growth while improving margins. Key drivers for potential EBIT margin improvement are (i) more favorable product and geographic mix and (ii) cost efficiency\/overhead optimization, mainly through economies of scale.<\/p>\n

      Adidas has a solid balance sheet and strong cash conversion.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

      \n\t\t\t\t
      \n\t\t\t\t\t\t\tAffidea has earned a reputation for clinical excellence, with a focus on quality care, as:\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t\t\t\t\t
      • Europe\u2019s most awarded diagnostic imaging provider<\/li>
      • A partner of choice for doctors, patients and payors<\/li>
      • A developer of new technologies with OEMs (\u201coriginal equipment manufacturers\u201d)<\/li><\/ul>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
        \n\t\t\t\t
        \n\t\t\t\t\t\t\t

        Over the past year, the Board and management have been strengthened with additional high-caliber appointments.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

        OverviewInvestment caseInfluence Affidea is benefiting from the sector\u2019s long-term structural tailwinds and its solid fundamentals and positioning: Large and growing market (e.g., ageing population and increasing focus on preventive medicine) Resilience through economic cycles, given the critical nature of the services and market undersupply Barriers to entry from: (i) sticky long-term contracts, (ii) high capital […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":33,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_canvas","meta":{"footnotes":""},"class_list":["post-378","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/app.agence2d.be\/gbl\/wp-json\/wp\/v2\/pages\/378","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/app.agence2d.be\/gbl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/app.agence2d.be\/gbl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/app.agence2d.be\/gbl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/app.agence2d.be\/gbl\/wp-json\/wp\/v2\/comments?post=378"}],"version-history":[{"count":10,"href":"https:\/\/app.agence2d.be\/gbl\/wp-json\/wp\/v2\/pages\/378\/revisions"}],"predecessor-version":[{"id":600,"href":"https:\/\/app.agence2d.be\/gbl\/wp-json\/wp\/v2\/pages\/378\/revisions\/600"}],"up":[{"embeddable":true,"href":"https:\/\/app.agence2d.be\/gbl\/wp-json\/wp\/v2\/pages\/33"}],"wp:attachment":[{"href":"https:\/\/app.agence2d.be\/gbl\/wp-json\/wp\/v2\/media?parent=378"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}